Clinical Trial Update: Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause [Phase 3]

View source ↗

Summary

Phase 3 study evaluating bazedoxifene/conjugated estrogens for menopausal vasomotor symptoms has completed. The snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Duavee (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Vasomotor Symptoms Associated With Menopause | Phase 3 | Status: COMPLETED